Business

Wall Street Week Ahead: Optimism among S&P 500 CEOs as Trump takes power

Wall Street Week Ahead: Optimism...

January 22

SAN FRANCISCO - U.S. President Donald Trump's administration is only hours old, but already a small parade of S&P 500 companies' chiefs have voiced optimism that his...

CEOs counsel taking Trump seriously, but not literally

CEOs counsel taking Trump seriously,...

January 21

DAVOS (Switzerland) — The word in Davos: Ignore the tweets. Executives gathered in the Swiss resort for the World Economic Forum this week keep repeating, like a soothing mantra...

Apple files $1 billion lawsuit against chip supplier Qualcomm

Apple files $1 billion lawsuit...

January 21

Apple Inc filed a $1 billion lawsuit against supplier Qualcomm Inc on Friday, days after the U.S. government accused the chip maker of resorting to anticompetitive tactics to...

U.S. bankruptcy court judge OKs $425 million for Avaya loan

U.S. bankruptcy court judge OKs $425...

January 21

NEW YORK - A U.S. bankruptcy court judge granted Avaya Inc approval on Friday to tap $425 million of the $725 million loan proposed to carry the telecommunications company...

Wall Street ends higher as Trump becomes president

Wall Street ends higher as Trump...

January 21

NEW YORK - U.S. stocks closed higher on Friday in a modest but broad-based advance as Donald Trump was sworn in as U.S. President, marking the first time in more than 50 years...

Morgan Stanley CEO James Gorman's 2016 pay up 7 pct to $22.5 million

Morgan Stanley CEO James Gorman's...

January 21

Morgan Stanley <MS.N> Chief Executive James Gorman's overall pay rose 7 percent in 2016 as the Wall Street bank's stock soared and it edged closer to hitting a key...

Dollar falls, U.S. stocks end higher after Trump inauguration

Dollar falls, U.S. stocks end higher...

January 21

NEW YORK - The dollar ended down while U.S. stock indexes rose in the last day of a choppy trading week, as investors reacted to President Donald Trump's inaugural speech.

Bristol-Myers lung cancer delay slams shares, keeps Merck in lead

Bristol-Myers lung cancer delay slams...

January 21

New YORK - Bristol-Myers Squibb Co <BMY.N> shares fell 11 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its...